CLINICAL_TRIALS trial_result · 2023-11-21

Clinical Trial Update: Actigraphy Improvement With Voxelotor (ActIVe) Study [Phase 4]

Phase 4 trial update evaluating actigraphy improvements with voxelotor (ActIVe) in sickle cell disease patients has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Pfizer | Conditions: Sickle Cell Disease, Sickle Cell Anemia | Phase 4 | Status: COMPLETED | Results posted: 2023-11-21